Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Revvity Revvity Announces Financial Results for the Second Quarter of 2024 July 29, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Board Declares Quarterly Dividend July 25, 2024 From Revvity Via Business Wire Tickers RVTY Revvity To Hold Earnings Call on Monday, July 29, 2024 July 09, 2024 From Revvity Via Business Wire Tickers RVTY Revvity to Present at Goldman Sachs Global Healthcare Conference May 28, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Announces Financial Results for the First Quarter of 2024 April 29, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Board Declares Quarterly Dividend April 25, 2024 From Revvity Via Business Wire Tickers RVTY Revvity to Present at BofA Securities 2024 Health Care Conference April 25, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Unveils a New Era of Automated Tuberculosis Testing April 24, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners April 15, 2024 From Revvity Via Business Wire Tickers RVTY Revvity To Hold Earnings Call on Monday, April 29, 2024 April 04, 2024 From Revvity Via Business Wire Tickers RVTY Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software April 02, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group March 20, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication March 18, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Introduces New Workflow to Accelerate Newborn Sequencing Research March 15, 2024 From Revvity Via Business Wire Revvity to Present at Upcoming Investor Conferences February 21, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions February 12, 2024 From Revvity Via Business Wire Tickers RVTY Propelling Diagnostics and Life Sciences Innovation from Early Phase Research to the Clinic: Revvity Showcases Cutting-Edge Solutions at SLAS2024 February 02, 2024 From Revvity Via Business Wire Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023 February 01, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors January 25, 2024 From Revvity Via Business Wire Tickers RVTY Revvity Board Declares Quarterly Dividend January 25, 2024 From Revvity Via Business Wire Tickers RVTY Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial Performance January 09, 2024 From Revvity Via Business Wire Tickers RVTY Revvity to Present at J.P. Morgan Healthcare Conference December 19, 2023 From Revvity Via Business Wire Tickers RVTY Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID November 27, 2023 From Revvity Via Business Wire Revvity to Present at Annual Evercore ISI HealthCONx Conference November 14, 2023 From Revvity Via Business Wire Tickers RVTY Revvity Announces Financial Results for the Third Quarter of 2023 October 30, 2023 From Revvity Via Business Wire Tickers RVTY Revvity Board Declares Quarterly Dividend October 26, 2023 From Revvity Via Business Wire Tickers RVTY Revvity Debuts Inaugural ESG Report October 26, 2023 From Revvity Via Business Wire Tickers RVTY Revvity and Element Biosciences Announce Collaboration to Improve Next Generation Sequencing Research Workflow October 16, 2023 From Revvity Via Business Wire Revvity To Hold Earnings Call on Monday, October 30, 2023 October 09, 2023 From Revvity Via Business Wire Tickers RVTY Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure September 26, 2023 From Revvity Via Business Wire Tickers RVTY Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.